Overview of patient characteristics and data quality. (A) Oncoprint of the treatment intensity, ELN classification, cytogenetic groups, and 81-gene next-generation sequencing (NGS) mutational profiles of the 362 patients with newly diagnosed AML in the in-house discovery cohort. The top histogram displays the number of mutations detected by NGS in each individual patient, whereas the right histogram depicts the frequency of each mutation across the cohort. (B) Overall frequency of protein detectability across the 362 samples. (C) Individual protein detectability in 362 samples. NA, not applicable.